Maoheng Zu

417 total citations
39 papers, 278 citations indexed

About

Maoheng Zu is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Maoheng Zu has authored 39 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 17 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Maoheng Zu's work include Liver Disease and Transplantation (22 papers), Organ Transplantation Techniques and Outcomes (12 papers) and Liver Disease Diagnosis and Treatment (8 papers). Maoheng Zu is often cited by papers focused on Liver Disease and Transplantation (22 papers), Organ Transplantation Techniques and Outcomes (12 papers) and Liver Disease Diagnosis and Treatment (8 papers). Maoheng Zu collaborates with scholars based in China and United States. Maoheng Zu's co-authors include Hao Xu, Ning Wei, Yuming Gu, Hao Xu, Wei Xu, Hui Wang, Bin Shen, Zhaojun Lu, Guixiang Sun and Peijin Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Maoheng Zu

36 papers receiving 274 citations

Peers

Maoheng Zu

HEPAT

SURGE

EPIDE

Zhaojun Lu China

Karol Nowak Poland

C. Barbara Italy

Linlin Wu China

G.F. Samelis Greece

Minodora Onisâi Romania

Daisuke Miyaki Japan

Takayuki Tohma Japan

F. Espósito Spain

Zhaojun Lu China

Maoheng Zu

76 ×0.5

HEPAT

71 ×0.7

SURGE

48 ×0.5

EPIDE

83 ×1.8

34 ×0.9

Citations per year, relative to Maoheng Zu Maoheng Zu (= 1×) peers Zhaojun Lu

Countries citing papers authored by Maoheng Zu

Since Specialization

Citations

This map shows the geographic impact of Maoheng Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maoheng Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maoheng Zu more than expected).

Fields of papers citing papers by Maoheng Zu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maoheng Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maoheng Zu. The network helps show where Maoheng Zu may publish in the future.

Co-authorship network of co-authors of Maoheng Zu

This figure shows the co-authorship network connecting the top 25 collaborators of Maoheng Zu. A scholar is included among the top collaborators of Maoheng Zu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maoheng Zu. Maoheng Zu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Hao, et al.. (2025). Clinical characteristics and risk factors of hepatocellular carcinoma development in Budd-Chiari syndrome patients after endovascular treatment. Digestive and Liver Disease. 57(6). 1301–1307. 1 indexed citations

Wang, Zhongkai, Ziwei Wang, Zhiyuan Zhang, et al.. (2022). Establishment and validation of a prediction model for the first recurrence of Budd–Chiari syndrome after endovascular treatment: a large sample size, single-center retrospective study. Hepatology International. 17(1). 159–169. 6 indexed citations

Xu, Hao, Lin Zhou, Ruifang Zhang, et al.. (2021). Alterations in Faecal Metagenomics and Serum Metabolomics Indicate Management Strategies for Patients With Budd-Chiari Syndrome. Frontiers in Cellular and Infection Microbiology. 11. 730091–730091. 4 indexed citations

Zhao, Qian, et al.. (2019). Hypertension Caused by Renal Arteriovenous Fistula with Multiple Renal Artery Aneurysms. Annals of Vascular Surgery. 70. 565.e11–565.e13. 2 indexed citations

Pang, Pengfei, Xiaojun Hu, Bin Zhou, et al.. (2018). DDX24 Mutations Associated With Malformations of Major Vessels to the Viscera. Hepatology. 69(2). 803–816. 10 indexed citations

Xu, Hao, et al.. (2017). Accessory hepatic vein stenting to treat primary Budd-Chiari syndrome. Zhonghua gan-dan waike zazhi. 23(10). 655–658. 1 indexed citations

Huang, Rui, et al.. (2016). Number and function of circulating endothelial progenitor cells in patients with primary Budd-Chiari syndrome. Clinics and Research in Hepatology and Gastroenterology. 41(2). 139–146. 1 indexed citations

Zhou, Wenjie, et al.. (2016). Budd–Chiari Syndrome in Young Chinese: Clinical Characteristics, Etiology and Outcome of Recanalization from a Single Center. CardioVascular and Interventional Radiology. 39(4). 557–565. 4 indexed citations

Su, Yong, et al.. (2016). Circulating microRNA profile in patients with membranous obstruction of the inferior vena cava. Experimental and Therapeutic Medicine. 11(3). 811–817. 4 indexed citations

10.

Zu, Maoheng, Jingjing Li, Yong Wang, et al.. (2015). Serum Iodine Is Increased in Subjects Having Budd–Chiari Syndrome. Biological Trace Element Research. 168(1). 21–24. 4 indexed citations

11.

Gu, Yuming, et al.. (2014). Diagnostic value of Golgi-73 and AFP in primary hepatocelluar carcinoma with single assay or combined detection:a meta-analysis. Zhonghua jianyan yixue zazhi. 37(5). 378–382. 1 indexed citations

12.

Xu, Hao, et al.. (2014). Strategy and Long-term Outcomes of Endovascular Treatment for Budd–Chiari Syndrome Complicated by Inferior Vena Caval Thrombosis. European Journal of Vascular and Endovascular Surgery. 47(5). 550–557. 30 indexed citations

13.

Zhang, Peijin, Jing Zhang, Guixiang Sun, et al.. (2014). Risk of Budd-Chiari Syndrome Associated with Factor V Leiden and G20210A Prothrombin Mutation: A Meta-Analysis. PLoS ONE. 9(4). e95719–e95719. 13 indexed citations

14.

Xu, Hao, et al.. (2014). Comparison osteopontin vs AFP for the diagnosis of HCC: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 38(6). 706–714. 59 indexed citations

15.

Zu, Maoheng. (2013). Budd-Chiari syndrome in youth: clinical features and interventional therapy. Zhonghua putong waike zazhi. 28(9). 686–689. 1 indexed citations

16.

Zu, Maoheng, et al.. (2013). Combining angioplasty with percutaneous microwave ablation for treating primary Budd-Chiari syndrome associated with hepatocellular carcinoma in two patients: A case report. Oncology Letters. 6(2). 612–616. 4 indexed citations

17.

Xu, Hao, et al.. (2013). Catheter-directed thrombolytic therapy combined with angioplasty for hepatic vein obstruction in Budd-Chiari syndrome complicated by thrombosis. Experimental and Therapeutic Medicine. 6(4). 1015–1021. 11 indexed citations

18.

Wang, Linyou, et al.. (2013). Application of 128-slice spiral CT combination scanning in the diagnosis of embolisms in pulmonary arteries and lower extremity veins. Experimental and Therapeutic Medicine. 7(2). 401–404. 4 indexed citations

19.

Shen, Bin, Xiaolong Wang, Hao Xu, et al.. (2013). Development of a canine model with diffuse hepatic vein obstruction (Budd-Chiari syndrome) via endovascular occlusion. Molecular Medicine Reports. 9(2). 607–613. 2 indexed citations

20.

Zu, Maoheng, et al.. (2010). [A review on the research status and trends of Budd-Chiari syndrome].. PubMed. 31(10). 1192–5. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact